TICKERNOMICS Sign up
Last Update: 2023-12-23 05:59:15
Certara Inc. ( CERT ) https://www.certara.com
17.71USD
Sector:
Healthcare
Industry:
Health Information Services
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
CERT
10.55%
SPY
30.72%
-55.92%
CERT
SPY
112.82%
CERT
0.00%
SPY
201.04%
CERT
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
2686.71
2725.22
0.61
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-79.66
7.61
2.55
3.11
0.00
-562.83
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-61.68
58.08
-1.37
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
3.86
-6.74
-5.89
0.00
Other Earnings and Cash Flow Stats:
Certara Inc. ( CERT ) Net Income TTM ($MM) is -34.50
Certara Inc. ( CERT ) Operating Income TTM ($MM) is -23.11
Certara Inc. ( CERT ) Owners' Earnings Annual ($MM) is 0.00
Certara Inc. ( CERT ) Current Price to Owners' Earnings ratio is 0.00
Certara Inc. ( CERT ) EBITDA TTM ($MM) is -20.14
Certara Inc. ( CERT ) EBITDA Margin is -1.37%
Capital Allocation:
Certara Inc. ( CERT ) has paid 0.00 dividends per share and bought back 0.422439 million shares in the past 12 months
Certara Inc. ( CERT ) has reduced its debt by 0.99399999999997 million USD in the last 12 months
Capital Structure:
Certara Inc. ( CERT ) Interest-bearing Debt ($MM) as of last quarter is 310
Certara Inc. ( CERT ) Annual Working Capital Investments ($MM) are -278
Certara Inc. ( CERT ) Book Value ($MM) as of last quarter is 1051
Certara Inc. ( CERT ) Debt/Capital as of last quarter is 29%
Other Balance Sheet Stats:
Certara Inc. ( CERT ) has 272 million in cash on hand as of last quarter
Certara Inc. ( CERT ) has 105 million of liabilities due within 12 months, and long term debt 291 as of last quarter
Certara Inc. ( CERT ) has 159 common shares outstanding as of last quarter
Certara Inc. ( CERT ) has 0 million USD of preferred stock value
Academic Scores:
Certara Inc. ( CERT ) Altman Z-Score is 3.69 as of last quarter
Certara Inc. ( CERT ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
Certara Inc. ( CERT ) largest shareholder is T. Rowe Price Investment Management,Inc. owning 3231958 shares at 57.24 ($MM) value
Leif E Pedersen(an insider) Sold 51224 shares of Certara Inc. ( CERT ) for the amount of $747870.40 on 2023-09-11
3.29% of Certara Inc. ( CERT ) is held by insiders, and 97.90% is held by institutions
Certara Inc. ( CERT ) went public on 2020-12-11
Other Certara Inc. ( CERT ) financial metrics:
FCF:87.58
Unlevered Free Cash Flow:0.00
EPS:-1.23
Operating Margin:-61.68
Gross Profit Margin:58.08
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-18.62
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Certara Inc. ( CERT ) :
Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, the Netherlands, the Philippines, Poland, Portugal, Spain, Switzerland, and the United Kingdom. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.